Echocardiographic manifestations in end-stage renal disease.
Takahide ItoKanako AkamatsuPublished in: Heart failure reviews (2023)
End-stage renal disease (ESRD) is a common but profound clinical condition, and it is associated with extremely increased morbidity and mortality. ESRD can represent four major echocardiographic findings-myocardial hypertrophy, heart failure, valvular calcification, and pericardial effusion. Multiple factors interplay leading to these abnormalities, including pressure/volume overload, oxidative stress, and neurohormonal imbalances. Uremic cardiomyopathy is characterized by left ventricular (LV) hypertrophy and marked diastolic dysfunction. In ESRD patients on hemodialysis, LV geometry is changeable bidirectionally between concentric and eccentric hypertrophy, depending upon changes in corporal fluid volume and arterial pressure, which eventually results in a characteristic of LV systolic dysfunction. Speckle tracking echocardiography enabling to detect subclinical disease might help prevent future advancement to heart failure. Heart valve calcification also is common in ESRD, keeping in mind which progresses faster than expected. In a modern era, pericardial effusion observed in ESRD patients tends to result from volume overload, rather than pericarditis. In this review, we introduce and discuss those four echocardiography-assessed findings of ESRD, with which known and conceivable pathophysiologies for each are incorporated.
Keyphrases
- end stage renal disease
- chronic kidney disease
- left ventricular
- peritoneal dialysis
- heart failure
- oxidative stress
- mitral valve
- cardiac resynchronization therapy
- hypertrophic cardiomyopathy
- aortic stenosis
- acute myocardial infarction
- left atrial
- pulmonary hypertension
- blood pressure
- atrial fibrillation
- ejection fraction
- aortic valve
- computed tomography
- dna damage
- autism spectrum disorder
- ischemia reperfusion injury
- current status
- resistance training